title: Effects of antibiotic therapy at drying off on mastitis in the dry period and early lactation.
abstract: Four strategies for selecting cows for intramammary therapy with benzathine cloxacillin at drying off were compared in 12 Victorian dairy herds. The bacteriological status of all quarters of all (1044) cows was determined just before drying off, within 2 d of calving, and again 3 to 5 months after calving. All cases of clinical mastitis (from calving to mid-lactation) were recorded. Cows not infected at drying off were allocated randomly to 2 subgroups of approximately 350 cows each: not infected, not treated (NI-NT), or not infected, all quarters treated (NI-AT). New infection rates in the dry period (3.8% for NI-NT vs 2.1% for NI-AT) and in early lactation (4.1% for NI-NT vs 3.9% for NI-AT) were low and these differences were not significant. Incidence of clinical mastitis in early lactation was almost 50% higher for the treated group of uninfected cows compared with the untreated group (0.05 less than p less than 0.1). Cows infected in one or more quarters at drying off were split randomly into 2 subgroups of approximately 170 cows each: infected, all quarters treated (I-AT), or infected quarters treated only (I-QT). The new infection rate during the dry period was nearly 4 times higher for I-QT (15.3%) due to significantly more new infections by Staphylococcus aureus and Streptococcus uberis.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Victorian Mastitis Research Group, Department of Agriculture and Rural Affairs, Bairnsdale, Victoria.
authors.forename: J W
authors.initials: JW
authors.lastname: Browning
authors.forename: G A
authors.initials: GA
authors.lastname: Mein
authors.forename: M
authors.initials: M
authors.lastname: Barton
authors.forename: T J
authors.initials: TJ
authors.lastname: Nicholls
authors.forename: P
authors.initials: P
authors.lastname: Brightling
mesh_terms: D000818:Animals; D002417:Cattle; D003023:Cloxacillin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D007774:Lactation; D008414:Mastitis, Bovine / Q000188:drug therapy*; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000662:veterinary*; D013290:Streptococcal Infections / Q000188:drug therapy / Q000662:veterinary*
chemical_list: C006692:benzathine cloxacillin; D003023:Cloxacillin